Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cuvillier, O.
Right arrow Articles by Spiegel, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cuvillier, O.
Right arrow Articles by Spiegel, S.
Related Collections
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 94 No. 10 (November 15), 1999: pp. 3583-3592

Liposomal ET-18-OCH3 Induces Cytochrome c-Mediated Apoptosis Independently of CD95 (APO-1/Fas) Signaling

Olivier Cuvillier, Eric Mayhew, Andrew S. Janoff, and Sarah Spiegel

From the Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC; and The Liposome Co, Inc, Princeton, NJ.

ELL-12, a liposome formulation of the ether-lipid 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine (ET-18-OCH3), is a nonmyelosuppressive antiproliferative agent that is more effective and less toxic than the ether lipid itself in tumor model systems. We found that ELL-12 induced apoptosis in Jurkat, H9, and U-937 cells that was preceded by activation of executioner caspases. In addition, ELL-12 triggered release of cytochrome c from mitochondria to the cytoplasm before caspase-9 activation. Apoptosis, activation of caspases, and cytochrome c release were blocked by Bcl-xL overexpression in Jurkat T cells, suggesting a critical role for mitochondria in ELL-12-triggered cell death. Furthermore, ELL-12 had no effect on expression of CD95 ligand, and inhibition of the Fas signaling pathway with antagonistic anti-CD95 antibody did not affect apoptosis induced by ELL-12. Hence, ELL-12 could be a promising adjunct for the treatment of tumors in addition to myelosuppressive chemotherapeutic drugs and/or those that use the CD95-ligand/receptor system to trigger apoptosis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
D. Pchejetski, N. Doumerc, M. Golzio, M. Naymark, J. Teissie, T. Kohama, J. Waxman, B. Malavaud, and O. Cuvillier
Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models
Mol. Cancer Ther., July 1, 2008; 7(7): 1836 - 1845.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Gomez-Brouchet, D. Pchejetski, L. Brizuela, V. Garcia, M.-F. Altie, M.-L. Maddelein, M.-B. Delisle, and O. Cuvillier
Critical Role for Sphingosine Kinase-1 in Regulating Survival of Neuroblastoma Cells Exposed to Amyloid-beta Peptide
Mol. Pharmacol., August 1, 2007; 72(2): 341 - 349.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Gajate and F. Mollinedo
Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts
Blood, January 15, 2007; 109(2): 711 - 719.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. Gajate, E. del Canto-Janez, A. U. Acuna, F. Amat-Guerri, E. Geijo, A. M. Santos-Beneit, R. J. Veldman, and F. Mollinedo
Intracellular Triggering of Fas Aggregation and Recruitment of Apoptotic Molecules into Fas-enriched Rafts in Selective Tumor Cell Apoptosis
J. Exp. Med., August 2, 2004; 200(3): 353 - 365.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Henderson, M. Mizzau, G. Paroni, R. Maestro, C. Schneider, and C. Brancolini
Role of Caspases, Bid, and p53 in the Apoptotic Response Triggered by Histone Deacetylase Inhibitors Trichostatin-A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA)
J. Biol. Chem., March 28, 2003; 278(14): 12579 - 12589.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Cuvillier and T. Levade
Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria
Blood, November 1, 2001; 98(9): 2828 - 2836.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
T. Kurita-Ochiai, K. Ochiai, and K. Fukushima
Butyric Acid-Induced T-Cell Apoptosis Is Mediated by Caspase-8 and -9 Activation in a Fas-Independent Manner
Clin. Vaccine Immunol., March 1, 2001; 8(2): 325 - 332.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Wieder, F. Essmann, A. Prokop, K. Schmelz, K. Schulze-Osthoff, R. Beyaert, B. Dorken, and P. T. Daniel
Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3
Blood, March 1, 2001; 97(5): 1378 - 1387.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Cuvillier, L. Edsall, and S. Spiegel
Involvement of Sphingosine in Mitochondria-dependent Fas-induced Apoptosis of Type II Jurkat T Cells
J. Biol. Chem., May 19, 2000; 275(21): 15691 - 15700.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 1999 by American Society of Hematology         Online ISSN: 1528-0020